Tirzepatide, the newest weight loss drug in India, is transforming the wellness market with its hormone-mimicking effects.

India's healthtech space is expected to witness disruption as weight loss drugs Ozempic and Mounjaro enter the market through ...

The patent on weight loss injection semaglutide is due to expire in 2031, which will let other companies make cut-price ...

Unless you are from another planet, you’ve heard all about the new weight loss medications taking the world by storm. These ...

Hers is a relatively new telehealth platform that offers prescription medications and customized support for weight loss. The ...

Ireland has pivoted to oppose contentious European Union reforms aimed at broadening access to new drugs and medicines, ...

A loophole that allowed compounding pharmacies to make cheaper, generic version of drugs like Ozempic and Wegovy has closed.

Starting today, pharmacies can no longer make cheaper alternatives to popular weight loss drugs, driving up costs for ...

In a major leap for African pharmaceutical innovation, the U.S. Food and Drug Administration (FDA) has officially accepted an ...

GoodRx ran a 12-month survey to better understand the dynamics that shape prescription medication fills and consumer behavior ...

Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...

Novo has a strong balance sheet and ended 2024 with about DKK 26 billion in cash and marketable securities and DKK 103 billion of debt (following the acquisition of Catalent manufacturing sites in ...